PRLog (Press Release) -
Jan 18, 2010 -
In light of recent developments, TimelessWealth.net, a leading investor and trader web portal, has issued a technical opinion on ADVENTRX Pharmaceuticals, Inc. (NYSE Amex:ANX) and Cord Blood America, Inc. (OTCBB:CBAI)
. The technical opinion has been published in the form of a chart analysis video available for review at:
http://timelesswealth.net/ta/anx1.html (ADVENTRX Pharmaceuticals, Inc.) and
http://timelesswealth.net/ta/cbai4.html (Cord Blood America, Inc.).
ADVENTRX Pharmaceuticals, Inc. (NYSE Amex:ANX) and Cord Blood America, Inc. (Nasdaq OTCBB:CBAI) have also been added to TimelessWealth’
s “Daily Watchlist”, a division of the site dedicated to highlighting securities displaying unusual technical events, chart patterns, or favorable fundamental activity. The “Daily Watchlist” is available for review at:
http://timelesswealth.net/dailywatch.htmlA new 52-week high was succeeded by a retracement in ADVENTRX Pharmaceuticals’
s market. Now the price will need to find support at a level where the ‘bulls’ will once again overwhelm the ‘bears’. ADVENTRX Pharmaceuticals recently announced that it has completed the sale of shares of its Series E convertible preferred stock pursuant to a registered direct offering to institutional investors, representing gross proceeds to ADVENTRX of approximately $19 million. ADVENTRX plans to use the net proceeds from the offering to fund activities relating to the commercial launch of ANX-530, including acquiring or developing sales, marketing and distribution capabilities and the associated regulatory compliance infrastructure, and to continue the development of ANX-514 in the United States, and for general corporate purposes.
Another natural, but rational decline in price, suggests strength among the ‘bulls’ in Cord Blood America’s market. Umbilical cord blood stem cell preservation company Cord Blood America, Inc. (OTCBB:CBAI)
said last Friday that the company has scheduled the opening of its Las Vegas corporate office and laboratory for 22 January 2010. The company said that the 17,000 square foot facility includes a state-of-the-
art laboratory for storage of multiple stem cell products and is expected to be one of the largest cryogenic storage facilities and stem cell labs in the US.
Photo:
http://www.prlog.org/10493058/1About TimelessWealth, Inc.
Timeless Wealth empowers investors with the confidence and tools that they need to succeed in any given market environment. Timely approaching an investment opportunity may be the difference between building wealth and struggling with finances. Our goal is to transform each and every member into a high net-worth individual through intelligent investments. Resultantly, we are building a stronger, more sophisticated equity market. For more information about TimelessWealth.net please visit: http://timelesswealth.net . For intraday updates please keep up with us on http://twitter.com/TimelessWealth .
